Pruritus of unknown origin and elevated total serum bile acid levels in patients without clinically apparent liver disease

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue 4, 2011, Pages 716-721

  Eisendle, Klaus ^a   Müller, Hansgeorg ^a   Ortner, Elisabeth ^a   Talasz, Heribert ^a   Graziadei, Ivo ^a   Vogel, Wolfgang ^a   Höpfl, Reinhard ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Bile acid metabolism; Biliary physiology; Experimental cholestasis

Indexed keywords

BILE ACID; COLESTYRAMINE; URSODEOXYCHOLIC ACID;

ADULT; AGED; ARTICLE; BILE ACID BLOOD LEVEL; CHOLESTASIS; CHRONIC DISEASE; CONTROLLED STUDY; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PRURITUS; PRURITUS OF UNKNOWN ORIGIN;

EID: 79952855708     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06522.x     Document Type: Article

References (28)

1. Jones EA, Bergasa NV. Why do cholestatic patients itch? Gut 1996; 38: 644-5.
2. Jones EA, Bergasa NV. The pruritus of cholestasis: from bile acids to opiate agonists. Hepatology 1990; 11: 884-7.
3. Bergasa NV. The pruritus of cholestasis. J. Hepatol. 2005; 43: 1078-88.
4. Jones EA, Bergasa NV. Evolving concepts of the pathogenesis and treatment of the pruritus of cholestasis. Can. J. Gastroenterol. 2000; 14: 33-40.
5. Glasova H, Beuers U. Extrahepatic manifestations of cholestasis. J. Gastroenterol. Hepatol. 2002; 17: 938-48.
6. Floreani A, Carderi I, Variola A etal. A novel multidrug-resistance protein 2 gene mutation identifies a subgroup of patients with primary biliary cirrhosis and pruritus. Hepatology 2006; 43: 1152-4.
7. Jones EA, Bergasa NV. The pruritus of cholestasis. Hepatology 1999; 29: 1003-6.
8. Mashige F, Tanaka N, Maki A etal. Direct spectrophotometry of total bile acids in serum. Clin. Chem. 1981; 27: 1352-6.
9. Stander S, Weisshaar E, Mettang T etal. Clinical classification of itch: a position paper of the international forum for the study of itch. Acta Derm. Venereol. 2007; 87: 291-4.
10. Schoenfield L, Sjovall J, Perman E. Bile acids on the skin of patients with pruritic hepatobiliary disease. Nature 1967; 213: 93.
11. Varadi DP. Pruritus induced by crude bile and purified bile acids. Experimental production of pruritus in human skin. Arch. Dermatol. 1974; 109: 678-81.
12. Kirby J, Heaton KW, Burton JL. Pruritic effect of bile salts. Br. Med. J. 1974; 4: 693-5.
13. Murphy GM, Ross A, Billing BH. Serum bile acids in primary biliary cirrhosis. Gut 1972; 13: 201-6.
14. Ghent CN, Bloomer JR, Klatskin G. Elevations in skin tissue levels of bile acids in human cholestasis: relation to serum levels and topruritus. Gastroenterology 1977; 73: 1125-30.
15. Monte MJ, Marin JJ, Antelo A, Vazquez-Tato J. Bile acids: chemistry, physiology, and pathophysiology. World J. Gastroenterol. 2009; 15: 804-16.
16. Esteller A. Physiology of bile secretion. World J. Gastroenterol. 2008; 14: 5641-9.
17. Martinez-Augustin O, Sanchez de Medina F. Intestinal bile acid physiology and pathophysiology. World J. Gastroenterol. 2008; 14: 5630-40.
18. Pauli-Magnus C, Meier PJ. Hepatocellular transporters and cholestasis. J. Clin. Gastroenterol. 2005; 39: 103-10.
19. Jacquemin E, Cresteil D, Manouvrier S etal. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet 1999; 353: 210-11.
20. Pauli-Magnus C, Lang T, Meier Y etal. Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy. Pharmacogenetics 2004; 14: 91-102.
21. Pauli-Magnus C, Meier PJ. Hepatobiliary transporters and drug-induced cholestasis. Hepatology 2006; 44: 778-87.
22. Meier Y, Pauli-Magnus C, Zanger UM etal. Interindividual variability of canalicular ATP-binding-cassette (ATP)-transporter expression in human liver. Hepatology 2006; 44: 62-74.
23. Lammert F, Marschall HU, Mattern S. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J. Hepatol. 2000; 33: 1012-21.
24. Bacq Y, Sapey T, Brechot MC etal. Intrahepatic cholestasis of pregnancy: a French prospective study. Hepatology 1997; 26: 358-64.
25. Ambros-Rudolph CM, Glatz M, Trauner M etal. The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from central Europe. Arch. Dermatol. 2007; 143: 757-62.
26. Datta DV, Sherlock S. Treatment of pruritus of obstructive jaundice with cholestyramine. Br. Med. J. 1963; 26: 216-9.
27. Matsuzaki Y, Tanaka N, Osuga T etal. Improvement of biliary enzyme levels and itching as a result of long term administration of ursodeoxycholic acid in primary biliary cirrhosis. Am. J. Gastroenterol. 1990; 85: 15-23.
28. Kondrackiene J, Beuers U, Kupcinskas L. Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy. Gastroenterology 2005; 129: 894-901.